With the FDA’s approval of the first tumor‑infiltrating lymphocyte (TIL) therapy to treat advanced melanoma, researchers seek to expand this type of cellular therapy to other solid tumors.

by Kendall K. Morgan

Forward Look

Newly approved drug combination leads to longer tumor responses in advanced urothelial cancer.

by Leah Lawrence

Forward Look

Research shows a scan can reveal treatment responses just one week after people with melanoma start immunotherapy.

by Anna Azvolinsky

Forward Look

Study suggests heated chemotherapy delivered to the abdominal cavity extends survival in advanced ovarian cancer.

by Kris Conner

Forward Look

Research suggests postmenopausal women over 50 with low-risk hormone receptor-positive breast cancer may forgo radiation after surgery.

by Darcy Lewis

Cathy Nobil-Dutton did all the right things to protect her health, but a uterine cancer diagnosis showed her life doesn’t always go as expected.

by Cathy Nobil-Dutton

Aspirin appears to activate an immune response against colorectal cancer in the early stages of the disease.

by Sandra Gordon

Scientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.

by Thomas Celona

Forward Look

Tests currently in development seek to offer greater accuracy and reach more people.

by Eric Fitzsimmons

AACR highlights team research that led to Lynch syndrome testing for all people with endometrial cancer in the U.K.

by Marci A. Landsmann